Inflammatory myopathies

Cardiovascular risk and cardiac involvement in idiopathic inflammatory myopathies: insights from a cross-sectional Swedish single-centre study

Scand J RheumatolPublished Cross-sectional study

Authors' conclusion

Cardiovascular complications in patients with IIM may result from an increased prevalence of traditional cardiovascular risk factors, such as higher BMI, diabetes mellitus, and dyslipidaemia, and/or from direct cardiac involvement, such as previous myocarditis. Cardiac involvement in IIM is notably associated with the IMNM subtype.

Study context

Population
Patients with IIM and age- and gender-matched healthy controls, Swedish single centre; ECG, transthoracic echocardiography, cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP)
Exposure
IIM patients vs age- and gender-matched healthy controls; IIM with vs without previous cardiac involvement
  • IIMn = 109
  • Healthy controlsn = 20reference
Outcome
Cardiovascular profile, including risk factors and cardiovascular abnormalities
Methodological detailssingle-centre, age- and gender-matched healthy controls
  • Single-centre
  • Age- and gender-matched healthy controls

Main finding

As reported in the abstract

  • IIM vs Healthy controls: P = 0.023
  • IIM vs Healthy controls: P = 0.024
  • IIM vs Healthy controls: P = 0.042
  • IIM vs Healthy controls: P = 0.041
  • IIM vs Healthy controls: P = 0.004
  • IIM vs Healthy controls: P = 0.041
  • IIM vs Healthy controls: P = 0.012
  • IIM vs Healthy controls: P = 0.034

Observational data: associations, not effects.

Further findings

OutcomeIIM with previous cardiac involvementIIM without cardiac involvementP value
IMNM subtype proportion, IIM with vs without previous cardiac involvement50%20%P = 0.037
cTnI levels (higher with cardiac involvement) · IIM with previous cardiac involvement vs IIM without cardiac involvement
P = 0.009

Original publication

Cardiovascular risk and cardiac involvement in idiopathic inflammatory myopathies: insights from a cross-sectional Swedish single-centre study. Scand J Rheumatol. Published 13 March 2025. doi:10.1080/03009742.2025.2470011

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.